Aβ43 levels determine the onset of pathological amyloid deposition
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Marc D Tambini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Brain Health Institute, Jacqueline Krieger Klein Center in Alzheime…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institutes of Health, National Institute on Aging.
Abstract (Originalsprache)
About 2% of Alzheimer's disease (AD) cases have early onset (FAD) and are caused by mutations in either Presenilins (PSEN1/2) or amyloid-β precursor protein (APP). PSEN1/2 catalyze production of Aβ peptides of different length from APP. Aβ peptides are the major components of amyloid plaques, a pathological lesion that characterizes AD. Analysis of mechanisms by which PSEN1/2 and APP mutations affect Aβ peptide compositions lead to the implication of the absolute or relative increase in Aβ42 in amyloid-β plaques formation. Here, to elucidate the formation of pathogenic Aβ cocktails leading to amyloid pathology, we utilized FAD rat knock-in models carrying the Swedish APP (Apps allele) and the PSEN1 L435F (Psen1LF allele) mutations. To accommodate the differences in the pathogenicity of rodent and human Aβ, these rat models are genetically engineered to express human Aβ species as both the Swedish mutant allele and the WT rat allele (called Apph) have been humanized in the Aβ-coding region. Analysis of the eight possible FAD mutant permutations indicates that the CNS levels of Aβ43, rather than absolute or relative increases in Aβ42, determine the onset of pathological amyloid deposition in FAD knock-in rats. Notably, Aβ43 was found in amyloid plaques in late onset AD and mild cognitive impairment cases, suggesting that the mechanisms initiating amyloid pathology in FAD knock-in rat reflect disease mechanisms driving amyloid pathology in late onset AD. This study helps clarifying the molecular determinants initiating amyloid pathology and supports therapeutic interventions targeting Aβ43 in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Physiology & Neuroscience, New Jersey Medical School, Brain Health Institute, Jacqueline Krieger Klein Center in Alzheimer's Disease and Neurodegeneration Research, Rutgers, The State Univers…
- Biospective Inc, Montreal, Quebec, Canada.
- Litwin-Zucker Center for the Study of Alzheimer's Disease and Memory Disorders, Feinstein Institutes for Medical Research, Institute of Molecular Medicine, Northwell Health System, Manhasset, New York, USA.
- Litwin-Zucker Center for the Study of Alzheimer's Disease and Memory Disorders, Feinstein Institutes for Medical Research, Institute of Molecular Medicine, Northwell Health System, Manhasset, New York, USA; Institute of…
Förderung
- NIA NIH HHS
- National Institutes of Health
- National Institute on Aging
- Albert Einstein College of Medicine, Yeshiva University
- University of Kentucky
- United States Atomic Energy Commission
Zitieren
APA
Tambini, M. D., Yin, T., Yesiltepe, M., Breuillaud, L., Zehntner, S. P., d'Abramo, C., Giliberto, L., & D'Adamio, L. (2023). Aβ43 levels determine the onset of pathological amyloid deposition. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104868
Vancouver
Tambini MD, Yin T, Yesiltepe M, Breuillaud L, Zehntner SP, d'Abramo C, et al. Aβ43 levels determine the onset of pathological amyloid deposition. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104868
BibTeX
@article{Tambini2023,
author = {Tambini, Marc D and Yin, Tao and Yesiltepe, Metin and Breuillaud, Lionel and Zehntner, Simone P and d'Abramo, Cristina and Giliberto, Luca and D'Adamio, Luciano},
title = {Aβ43 levels determine the onset of pathological amyloid deposition},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104868}
}
EUVIMED